BigHat Bio
Ryan Henrici MD PhD serves as Vice President of Discovery Medicine at BigHat Biosciences since January 2020, overseeing global Discovery Biology and Translational Research strategy, pipeline management, and new program evaluation for next-generation antibody therapeutics. Prior roles include Senior Director of Translational Research and Director of Translational Research, focusing on therapeutic program strategy, target identification, and antibody optimization across multiple therapeutic areas. Additionally, Ryan holds an Adjunct Associate Professorship at the University of Pennsylvania School of Medicine, teaching various subjects, and serves as a Clinical Investigator at Indiana University School of Medicine, co-leading a clinical study on antimalarial treatment outcomes in children with sickle cell anemia. Education includes an M.D. from the University of Pennsylvania School of Medicine, a Ph.D. in Infectious and Tropical Disease from the London School of Hygiene and Tropical Medicine, and a BSc (Hons) in Biochemistry and Molecular Biology from Schreyer Honors College at Penn State.
This person is not in any teams
This person is not in any offices
BigHat Bio
1 followers
BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases.